An OPTIMIZE Study Retrospective Analysis for Management of Telaprevir-Treated Hepatitis C Virus (HCV)-Infected Patients by Use of the Abbott RealTime HCV RNA Assay

Protease inhibitor (PI)-based response-guided triple therapies for hepatitis C virus (HCV) infection are still widely used. Noncirrhotic treatment-naive and prior relapser patients receiving telaprevir-based treatment are eligible for shorter, 24-week total therapy if HCV RNA is undetectable at both...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Microbiol
Autors principals: Sarrazin, Christoph, Dierynck, Inge, Cloherty, Gavin, Ghys, Anne, Janssen, Katrien, Luo, Donghan, Witek, James, Buti, Maria, Picchio, Gaston, De Meyer, Sandra
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2015
Matèries:
Virology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4365219/
https://ncbi.nlm.nih.gov/pubmed/25653396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.03030-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars